• No results found

Raman spectroscopy of the low dimensional antiferromagnet SrRu2O6 with large Néel temperature

N/A
N/A
Protected

Academic year: 2020

Share "Raman spectroscopy of the low dimensional antiferromagnet SrRu2O6 with large Néel temperature"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Figure

FIG. 1:Experimental phonon Raman spectra of SrRu2O6measured at 300 K in different polarization geometries.a)-XXand XY, b) ZZ and XZ
TABLE I: Comparison between calculated (at the Γ point)and experimentally found values of phonon frequencies forSrRu2O6
Fig. 5(a).
FIG. 6:Magnon density of states for SrRuintegration of the (4) spectrum. Inset shows the coordinate2O6 obtained bysystem used in the calculations.
+3

References

Related documents

We asked two specific questions: (i) is lean mass more important that fat mass as a determinant of bone mineral density in postmenopausal women; and (ii) given the sampling

It was decided that with the presence of such significant red flag signs that she should undergo advanced imaging, in this case an MRI, that revealed an underlying malignancy, which

The overall aim of this study was to inform the devel- opment of equitable and accessible mental healthcare integrated into primary care services for people with se- vere

Some features of the field induced phase transition accompanied by the vac- uum creation of an electron-positron plasma (EPP) in strong time-dependent electric fields have been

On the contrary, HeLa cells exposed to CNPs containing identical amounts of CNTs attached to their surfaces displayed.. 1XFOHXV

The comparable nucleophilicity of the exocyclic NH 2 group and endocyclic NH in 3(5)-aminopyrazoles is considered as it causes literature controversy associated with

After successfully supporting the development of the wind power technology, an approach is needed to include the owners of wind turbines in the task of realizing other ways, other

In the present study, we developed a simple and rapid method for the simultaneous measurement of plasma concentrations of four first-line drugs (pyrazinamide,